News

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...
In a stunning reversal, Google DeepMind acquires Windsurf’s top talent just weeks after OpenAI’s $3B deal collapsed over IP ...
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...
Scientists from OpenAI, Google, Anthropic and Meta unite in rare collaboration to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...
This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...
Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...